14 / 108
The Company proposes that the following fourteen individuals be elected to the Board of
Directors. These individuals have been nominated by the Corporate Governance Committee
of the Board of Directors and, if elected, are willing to serve until the next Annual Meeting of
Shareholders and until their successors have been elected and qualified. The people named
in the accompanying proxy (or their substitutes) will vote to elect these nominees unless
specifically instructed to the contrary. However, if any nominee becomes unable or unwilling
to serve or is otherwise unavailable for election, the people named in the proxy (or their
substitutes) will have discretionary authority to vote or to refrain from voting on any substitute
nominee. The Board of Directors has no reason to believe that any of the nominees will be
unable or unwilling to serve. Our Board believes it is appropriate to maintain a diverse balance
of longer tenured members, who bring stability and valuable Company-specific knowledge with
an historical perspective, and newer members, who bring fresh perspectives and new ideas.
All of the nominees introduced below are currently members of our Board. Ms. Lloyd was
appointed as a director, upon the recommendation of the Corporate Governance Committee,
on January 6, 2017. Ms. Lloyd was recommended for the Board by the Chairman of the Audit
and Risk Committee.
Proposal 1:
Election of Directors
DIRECTOR SKILLS SUMMARY
Name
Current or
former CEO
Operations
Experience Independent
Japanese
Market
Experience
Financial
Expertise
Risk Mgmt.
Experience
Industry
Experience
Public Health
Experience
Daniel P. Amos
Paul S. Amos II
W. Paul Bowers
Kriss Cloninger III
Toshihiko Fukuzawa
Elizabeth J. Hudson
Douglas W. Johnson
Robert B. Johnson
Thomas J. Kenny
Charles B. Knapp
Karole F. Lloyd
Joseph L. Moskowitz
Barbara K. Rimer, DrPH
Melvin T. Stith
The Board of Directors recommends a vote
“for”
the
election of each of the following nominees as directors.
FOR
AFLAC INCORPORATED
2017 PROXY STATEMENT
8